CD274 and gastric carcinoma: The connection of PD-L1/PD-1 expression with various clinico-pathological characteristics might supply as a surrogate marker of PD-L1-positive gastric carcinomas, as well as can allow for improving the immune checkpoint treatment possibilities [61].